A new BRAIN Initiative atlas showcases the diverse cell populations within the human hypothalamus, paving the way to discovering novel cellular targets for obesity and metabolic disease
Wegovy (semaglutide) produces the greatest weight loss in teenagers, but a study by Columbia researchers finds that the trendy obesity drug is not cost-effective at its current price.
Losing weight is often the easy part; keeping it off is usually a struggle. In the POWERS study, Columbia researchers are now delving into the reasons why some people succeed and some fail.
Pediatric gastroenterologist Jennifer Woo Baidal explains that obesity may increase the risk of a serious liver disease at a much younger age than once thought.
Michael Rosenbaum, MD, director of the new FIT clinic at Columbia for treatment of pediatric obesity, explains his research on weight loss and metabolism.
College of Physicians & Surgeons Dean Lee Goldman discusses his new book, which examines the role DNA plays in attempting to treat diabetes, obesity, and cardiovascular disease.